Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Epitope
92%
Immunology
88%
Influenza
82%
Hemagglutinin
75%
Spike
70%
B Cell
62%
Receptor Binding
58%
Neutralizing Antibody
36%
Binding Site
36%
Memory B Cell
35%
Germinal Center
33%
Influenza Virus
32%
Complement Receptor
31%
Influenza Virus Hemagglutinin
31%
Monoclonal Antibody
29%
Integrin
27%
Infectious Agent
26%
Antibody Response
25%
Hemagglutinin (Influenza)
21%
IC3b
21%
Omicron Coronavirus Variant
17%
Phagocytosis
16%
Immune Response
16%
Virus Hemagglutinin
16%
CD18
15%
Glycoprotein
14%
Influenza B Virus
13%
Influenza Vaccine
13%
Germ Cell
13%
Ligand Binding
11%
Amino Terminal Sequence
11%
Complement Activation
11%
Complement Component C3d
11%
Bird
10%
Follicular Dendritic Cells
10%
Herpesviridae
10%
Virus Transmission
10%
Antibody-Dependent Cell-Mediated Cytotoxicity
10%
Mosaicism
10%
Opsonin
10%
Competitive Inhibition
10%
Clonal Evolution
10%
Osteopontin
10%
Lactobacillus sakei
10%
Anaphylatoxin
10%
Complement Component 5a
10%
Antibodies
10%
Innate Immune System
9%
Somatic Hypermutation
9%
Keyphrases
Hemagglutinin
73%
COVID-19
63%
Receptor-binding Domain
60%
Epitope
56%
Vaccine Response
40%
Memory B Cells
37%
Virus
34%
B Cells
33%
Influenza Virus
33%
Vaccination
33%
Influenza Virus Hemagglutinin
31%
Influenza
30%
Complement Receptor 3
30%
Variants of Concern
28%
Conserved Epitopes
28%
Germinal Center
26%
SARS-CoV-2 Spike
25%
Monoclonal Antibody
24%
Influenza Hemagglutinin
22%
Viral Epitopes
21%
Antibody Response
21%
IC3b
21%
Germinal Center B Cells
20%
Integrin
20%
Acid Tolerance
20%
Neutralizing Activity
19%
D-tagatose
18%
Neutralizing Antibodies
17%
Phagocytosis
16%
Immune Response
16%
Molecular Mechanism
16%
Universal Vaccine
16%
Human Antibody
15%
MRNA Vaccine
15%
CD18
15%
B Cell Repertoire
15%
Antibody Repertoire
15%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
15%
I-domain
14%
Emerging Variants
14%
Influenza B Virus
13%
Germ Cells
13%
Broadly Protective
13%
Escherichia Coli
13%
SARS-CoV-2 Variants of Concern
12%
High Affinity
12%
Influenza Vaccination
12%
Influenza Immunization
12%
Autoreactive
11%
Human B Cells
11%